Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia: comparison with healthy individuals with normal serum urate concentrations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-1146
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia: comparison with healthy individuals with normal serum urate concentrations ; volume:9 ; number:1 ; day:30 ; month:4 ; year:2016 ; pages:1-9 ; date:12.2016
Journal of foot and ankle research ; 9, Heft 1 (30.4.2016), 1-9, 12.2016
- Urheber
-
Stewart, Sarah
- Beteiligte Personen und Organisationen
-
Dalbeth, Nicola
Vandal, Alain C.
Rome, Keith
SpringerLink (Online service)
- DOI
-
10.1186/s13047-016-0147-4
- URN
-
urn:nbn:de:1111-201605041350
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stewart, Sarah
- Dalbeth, Nicola
- Vandal, Alain C.
- Rome, Keith
- SpringerLink (Online service)
Ähnliche Objekte (12)
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Adherence with urate-lowering therapies for the treatment of gout
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Susceptibility genes of hyperuricemia and gout
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of worn and new footwear on plantar pressure in people with gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Adherence with urate-lowering therapies for the treatment of gout
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Susceptibility genes of hyperuricemia and gout
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of worn and new footwear on plantar pressure in people with gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Adherence with urate-lowering therapies for the treatment of gout
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Susceptibility genes of hyperuricemia and gout
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of worn and new footwear on plantar pressure in people with gout